BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ambjørner SEB, Wiese M, Köhler SC, Svindt J, Lund XL, Gajhede M, Saaby L, Brodin B, Rump S, Weigt H, Brünner N, Stenvang J. The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP. Cells 2020;9:E613. [PMID: 32143347 DOI: 10.3390/cells9030613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Hao C, Lane J, Jiang WG. Osteopontin and Cancer: Insights into Its Role in Drug Resistance. Biomedicines 2023;11. [PMID: 36672705 DOI: 10.3390/biomedicines11010197] [Reference Citation Analysis]
2 Mohamed Nabil Helaly A, Ghorab D. Perspective Chapter: Topoisomerase 1 and Colo Rectal Carcinoma. DNA Replication - Mechanisms, Epigenetics, and Gene Therapy Applications [Working Title] 2022. [DOI: 10.5772/intechopen.108988] [Reference Citation Analysis]
3 Luo J, Yuan J, Yang Y, Jiang Y, Yan J, Tong Q. Special AT-rich sequence binding protein 1 promotes multidrug resistance in gastric cancer by regulation of Ezrin to alter subcellular localization of ATP-binding cassette transporters. Cancer Sci 2022. [PMID: 36522839 DOI: 10.1111/cas.15693] [Reference Citation Analysis]
4 El Ashry ESH, Awad LF, Badawy ME, Rabea EI, Ibrahim NA, Al Moaty MNA. Synthesis, antibacterial, antioxidant, and molecular docking studies of 6-methylpyrimidin-4(3H)-one and oxo-1,2,4-triazolo[4,3-a]pyrimidine derivatives. Journal of Molecular Structure 2022;1249:131551. [DOI: 10.1016/j.molstruc.2021.131551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Petersen MJ, Lund XL, Semple SJ, Buirchell B, Franzyk H, Gajhede M, Kongstad KT, Stenvang J, Staerk D. Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant Eremophila galeata Chinnock. Biomolecules 2021;11:1534. [PMID: 34680166 DOI: 10.3390/biom11101534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Xiao H, Zheng Y, Ma L, Tian L, Sun Q. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance. Front Pharmacol 2021;12:648407. [PMID: 33953682 DOI: 10.3389/fphar.2021.648407] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 27.5] [Reference Citation Analysis]
7 Zhao Y, Chen Y, Wang J, Liu L. Effects of ATP-binding cassette transporter G2 in extracellular vesicles on drug resistance of laryngeal cancer cells in in vivo and in vitro. Oncol Lett 2021;21:364. [PMID: 33747221 DOI: 10.3892/ol.2021.12625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wilke DV, Jimenez PC, Branco PC, Rezende-Teixeira P, Trindade-Silva AE, Bauermeister A, Lopes NP, Costa-Lotufo LV. Anticancer Potential of Compounds from the Brazilian Blue Amazon. Planta Med 2021;87:49-70. [PMID: 33142347 DOI: 10.1055/a-1257-8402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kallunki T. Seeking and Exploring Efficient Ways to Target Cancer. Cells 2020;9:E2117. [PMID: 32957725 DOI: 10.3390/cells9092117] [Reference Citation Analysis]
10 Ashar YV, Zhou J, Gupta P, Teng QX, Lei ZN, Reznik SE, Lusvarghi S, Wurpel J, Ambudkar SV, Chen ZS. BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance. Cancers (Basel) 2020;12:E2502. [PMID: 32899268 DOI: 10.3390/cancers12092502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
11 Stenvang J, Budinská E, van Cutsem E, Bosman F, Popovici V, Brünner N. An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. Cancers (Basel) 2020;12:E977. [PMID: 32326511 DOI: 10.3390/cancers12040977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]